METTL3 also plays a role in sorafenib sensitivity in HCC as METTL3 knockdown cells exhibited a two-fold increase in the IC50 of sorafenib compared to METTL3 expressing cells [58]. Here, METTL3 is linked to hepatocellular carcinoma.